-
Angiotensin II: From Receptor Signal to AAA Models
2026-09-29
Discover how Angiotensin II and Asp-Arg-Val-Tyr-Ile-His-Pro-Phe can be used to connect receptor signaling with vascular remodeling and abdominal aortic aneurysm models. This guide emphasizes assay architecture, exposure-informed interpretation, and practical experimental decisions beyond standard pathway summaries.
-
Thioredoxin Controls CHK1 Inhibitor Sensitivity in NSCLC
2026-09-29
This Nature Communications study identifies thioredoxin 1 as a determinant of non-small cell lung cancer sensitivity to CHK1 inhibition and connects that phenotype to redox control of ribonucleotide reductase. Its findings support a mechanistically defined combination strategy in which thioredoxin reductase inhibition disrupts deoxynucleotide production and may improve the activity of CHK1 inhibitors, although clinical translation remains unproven.
-
Physiological and Pathological Aβ in Human Slices
2026-09-28
The reference study uses live human brain slice cultures to distinguish how physiological versus Alzheimer’s disease-associated amyloid-β affects synapses. Its results show that both increasing and decreasing physiological Aβ can reduce synaptophysin puncta, whereas Aβ-containing Alzheimer’s brain extract produces postsynaptic uptake and presynaptic loss without the same synaptic transcript response.
-
4-Ethylphenyl Sulfate at the Blood–Material Interface
2026-09-28
4-Ethylphenyl sulfate is relevant not only to microbiota and renal research, but also to how uremic plasma interacts with blood-contacting materials. This article examines what a recent protein-adsorption study does—and does not—establish, then translates its findings into practical assay-design decisions.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-09-27
FITC-Concanavalin A is a fluorescent lectin conjugate for detecting accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids in cell or tissue samples. Use it for carbohydrate-focused immunofluorescence staining and flow cytometry, not as a general stain or a substitute for target-specific identification.
-
0.4% Trypan Blue Solution: Practical Cell Counting
2026-09-26
0.4% Trypan Blue Solution supports rapid cell viability measurement and cell counting by helping distinguish cells with intact membranes from cells that take up the dye. It is intended for research workflows, not diagnostic or medical use, and it does not replace assays that distinguish specific cell-death pathways.
-
CKLF1, Neutrophils, and New Stroke Research Questions
2026-09-25
A translational perspective on how CKLF1-mediated neutrophil recruitment may shape post-stroke recovery, what the esculetin study establishes, and how to design rigorous follow-up experiments without overstating the evidence.
-
METTL14–SMN Signaling and m6A Homeostasis
2026-09-25
The study identifies an arginine methylation-dependent interaction between METTL14 and SMN that connects m6A regulation with DNA repair gene expression and cellular responses to DNA damage. Patient-derived fibroblast and mouse findings suggest relevance to spinal muscular atrophy and early development, while also defining important limits for interpreting the pathway across tissues.
-
Cy5-UTP for Fluorescent RNA Probe Workflows
2026-09-24
Cy5-UTP supports direct, far-red visualization of RNA made by in vitro transcription, with practical uses in FISH, dual-color assays, and probe quality checks. This guide covers a tunable labeling workflow and explains how fluorescent RNA can inform—without being mistaken for proof of—mRNA delivery in brain-targeting nanoparticle research.
-
Reading Phosphorylation Beyond the Antibody
2026-09-24
A rice salt-response study shows how phosphorylation can tune both the activity and abundance of a calcium channel over time. We explore what that means for experimental design—and where sequence-independent Phosbind Biotin detection can add value without replacing site-specific validation.
-
0.4% Trypan Blue Solution: Practical Cell Counting
2026-09-23
0.4% Trypan Blue Solution supports direct cell viability measurement by staining dead or membrane-damaged cells blue while viable cells remain unstained. It is intended for research workflows such as cell counting and cytotoxicity assays, not for diagnostic or medical use, and it does not identify the cause of cell death.
-
TRIM21, ERK1/2, and Drug Resistance in Pituitary Adenomas
2026-09-23
The reference study identifies TRIM21 as a regulator of ERK1/2 ubiquitination, phosphorylation, proliferation, and dopamine-agonist resistance in pituitary adenomas. Its combination of CRISPR screening, proteomic analysis, biochemical validation, and drug screening highlights TRIM21 suppression as a preclinical strategy, while also revealing important feedback-dependent effects of TRIM21 abundance.
-
E-4031 for 3D hERG Cardiac Electrophysiology
2026-09-22
E-4031 converts a shell-MEA cardiac organoid into a practical model of repolarization stress, enabling spatial analysis of QT interval prolongation, conduction changes, and arrhythmia-like events. This workflow combines a nanomolar hERG perturbation with 3D electrical mapping and calcium validation for more informative cardiac electrophysiology research.
-
Cy5-UTP RNA Labeling Workflow
2026-09-22
Cy5-UTP enables direct far-red visualization of RNA produced by T7 in vitro transcription, making it useful for FISH, multiplex assays, and fluorescent tracking of formulated mRNA. This guide connects practical RNA probe synthesis with the lung-targeted LNP findings of a recent reference study while clearly separating fluorescence-based distribution data from functional expression measurements.
-
HOXC9 Drives ESCC Growth via AKT/mTOR
2026-09-21
This study identifies HOXC9 as an overexpressed regulator of esophageal squamous cell carcinoma associated with proliferation, apoptosis resistance, and poorer survival. Using genetic perturbation, transcriptomics, pathway inhibition, and xenograft models, the authors link HOXC9-driven phenotypes to AKT/mTOR signaling while defining important limitations for biomarker and therapeutic translation.